Search
for
Sort by
Research 30 of 156
- Is sulfonamide group of tamsulosin main factor in the pathophysiology of floppy iris syndrome?
- [4-t-Butylphenyl]-N-(4-imidazol-1-yl phenyl)sulfonamide (ISCK03) inhibits SCF/c-kit signaling in 501mel human melanoma cells and abolishes melanin production in mice and brownish guinea pigs
- Circumventing Mukaiyama oxidation: selective S–O bond formation via sulfenamide–alcohol coupling
- Toxic Epidermal Necrolysis
- Discovery of New Drug Therapies Based on the Study of Adverse Reactions
- Anaemia and skin disease
- Diseases of the skin. Drug ill effects on the skin.
- Dermatological drugs, topical agents, and cosmetics
- Drug Eruptions
- Sights for Sore Eyes and Disappointments in Psychopharmacology
- Psychoactive drugs and skin
- TOXIC EPIDERMAL NECROLYSIS
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases
- Cutaneous Reactions to Drugs
- Simultaneous Estimation of Finasteride and Tamsulosin Hydrochloride in Combined Dosage Forms by RP-HPLC-PDA Method
- UV SPECTROPHOTOMETRIC METHOD FOR SIMULTANEOUS DETERMINATION OF FINASTERIDE AND TAMSULOSIN IN COMBINED DOSAGE FORM
- Diuretics
- TOC
- Update on nail disorders
- Metabolic syndrome
- Incidence of adverse cutaneous drug reactions in a Mexican sample: an exploratory study on their association to tumour necrosis factor alpha TNF2 allele
- Steroid Sulfatase: Molecular Biology, Regulation, and Inhibition
- Severe cutaneous adverse reactions to drugs
- The pharmacology of methotrexate
- Prevention of Chemotherapy-Induced Alopecia in Rats by CDK Inhibitors
- Superficial granulomatous pyoderma: A localized vegetative form of pyoderma gangrenosum
- Drug-Induced Skin, Nail and Hair Disorders
- Methotrexate in dermatology
- Safety of dermatologic medications in pregnancy and lactation
- Mechanisms of Disease: selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome